Regulation of mineralocorticoid receptor activation by circadian protein TIMELESS.


Journal

Journal of molecular endocrinology
ISSN: 1479-6813
Titre abrégé: J Mol Endocrinol
Pays: England
ID NLM: 8902617

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 01 09 2022
accepted: 13 09 2022
pubmed: 14 9 2022
medline: 15 12 2022
entrez: 13 9 2022
Statut: epublish

Résumé

The mineralocorticoid receptor (MR) is a ligand-activated transcription factor that regulates cardiorenal physiology and disease. Ligand-dependent MR transactivation involves a conformational change in the MR and recruitment of coregulatory proteins to form a unique DNA-binding complex at the hormone response element in target gene promoters. Differences in the recruitment of coregulatory proteins can promote tissue-, ligand- or gene-specific transcriptional outputs. The goal of this study was to evaluate the circadian protein TIMELESS as a selective regulator of MR transactivation. TIMELESS has an established role in cell cycle regulation and DNA repair. TIMELESS may not be central to mammalian clock function and does not bind DNA; however, RNA and protein levels oscillate over 24 h. Co-expression of TIMELESS down-regulated MR transactivation of an MR-responsive reporter in HEK293 cells, yet enhanced transactivation mediated by other steroid receptors. TIMELESS markedly inhibited MR transactivation of synthetic and native gene promoters and expression of MR target genes in H9c2 cardiac myoblasts. Immunofluorescence showed aldosterone induces colocalisation of TIMELESS and MR, although a direct interaction was not confirmed by coimmunoprecipitation. Potential regulation of circadian clock targets cryptochrome 1 and 2 by TIMELESS was not detected. However, our data suggest that these effects may involve TIMELESS coactivation of oestrogen receptor alpha (ERα). Taken together, these data suggest that TIMELESS may contribute to MR transcriptional outputs via enhancing ERα inhibitory actions on MR transactivation. Given the variable expression of TIMELESS in different cell types, these data offer new opportunities for the development of MR modulators with selective actions.

Identifiants

pubmed: 36099062
doi: 10.1530/JME-21-0279
pii: JME-21-0279
doi:
pii:

Substances chimiques

DNA 9007-49-2
Ligands 0
Mineralocorticoids 0
Receptors, Mineralocorticoid 0
TIMELESS protein, human 0
Cell Cycle Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Colin D Clyne (CD)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.

Kevin P Kusnadi (KP)

Cardiovascular Endocrinology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.

Alexander Cowcher (A)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.

James Morgan (J)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.

Jun Yang (J)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.

Peter J Fuller (PJ)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.

Morag J Young (MJ)

Cardiovascular Endocrinology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
University of Melbourne and Baker HDI Department of Cardiometabolic Health and Disease, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH